Overview

• CEO Stephen Gillett told employees in a memo that workforce reductions were executed and all affected staff were notified, though the number was not disclosed.
• The long-running Devices program will be fully wound down after years of work on projects such as a clinical study watch, a retinal camera, and collaborations tied to glucose monitoring.
• Verily said the restructuring concentrates resources on its precision health platform and a broader data and AI strategy.
• Despite the shutdown, the company will continue supporting customers using the Numetric Watch in active clinical studies.
• The move follows a multi-year simplification that began in 2023, including the sale of its insurance business to Elevance Health, alongside reported benefit reductions and healthcare-sector salary re-benchmarking.